Market Closed -
Other stock markets
|
Pre-market 07:00:14 am | |||
79.43 USD | +0.14% | 79.52 | +0.12% |
Mar. 15 | Piper Sandler Adjusts Price Target on CVS Health to $94 From $93, Maintains Overweight Rating | MT |
Mar. 07 | UnitedHealth hack clouds outlook for insurers' medical costs | RE |
Evolution of the average Target Price on CVS Health Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CVS Health Corporation
Piper Sandler | |
Leerink Partners | |
RBC Capital Markets | |
Deutsche Bank Securities | |
HSBC | |
TD Cowen | |
Bernstein | |
Evercore ISI | |
Wolfe Research | |
Edward Jones | |
DA Davidson | |
Raymond James | |
UBS | |
Truist Securities | |
Morgan Stanley | |
Barclays | |
Jefferies & Co. | |
Mizuho Securities | |
JPMorgan Chase | |
Wells Fargo Securities | |
Goldman Sachs | |
Cantor Fitzgerald | |
BofA Securities | |
Credit Suisse | |
Loop Capital | |
Tigress Financial | |
BMO Capital | |
Baird | |
Seaport Global Securities | |
Guggenheim |
EPS Revisions
- Stock
- Equities
- Stock CVS Health Corporation - Nyse
- Consensus CVS Health Corporation